Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
SKYE
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w low +43.9%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
bioscience
investors
class
action
securities
firm
nimacimab
lawsuit
deadline
2025
rosen
drug
2024
statements
october
lead
about
january
misleading
clinical
SKYE
Skye Bioscience, Inc. Common Stock
Stonvex
StonvexStonvexStonvexStonvex